It’s been a very busy few months at Vicore as we’ve continued to progress our studies into IPF and of course our COVID study, ATTRACT.
As we now have some initial top line positive results from ATTRACT, we asked CMO Rohit Batta to talk about what the ATTRACT results might mean for COVID treatment, and if there is correlation from these results to our ongoing studies into rare lung diseases.